Skip to main content
Log in

The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The purpose of the study was to investigate the in vivo metabolic pathway of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine (substrate) in rats. Firstly its potential metabolites, i.e. N-dealkylation, ring scission of pyridazine and aromatic hydroxylation products, were synthesized and then the substrate was given orally (100 mg/kg) to male or female Wistar rats at a dose of 100 mg/kg to body weight. Blood samples were collected at 0, 1, 2, 4, 6 and 8 hours after administration of substrate and blood was centrifuged to obtain serum. The substrate and its potential metabolites were separated using a gradient HPLC method on a reverse phase system. This study revealed that 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine was not metabolized to the proposed metabolites and was present unchanged in the serum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balkan A., Özkanli F., Ünsal O., Gören Z., Terzioglu B. (2003): Studies on some 3-oxo-5-benzylidene-6-methyl-(4H)-2-substituted pyridazines with antinociceptive and antiinflammatory activities, FAB AD J. Pharm. Sei. 28, 19–25.

    CAS  Google Scholar 

  2. Hashizume T., Mise M, Matsumoto S., Terauchi Y., Fujii T., Imaoka S., Funae Y., Kamataki T., Miyazaki H. (2001): A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine. Drug Metab. Dispos. 29(6), 798–805.

    CAS  PubMed  Google Scholar 

  3. Hashizume T., Imaoka S., Mise M., Terauchi Y., Fujii T., Miyazaki H., Kamataki T., Funae Y. (2002): Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J. Pharmacol. Exp. Ther. 300(2), 298–304.

    Article  CAS  PubMed  Google Scholar 

  4. Heykants J., Pardeol L., Janssen P.A.J. (1971): On the distribution and metabolism of azaperone (R 1929) in the rat and pig. Arzneim.-Forsch. (Drug Res.) 7,982–984.

    Google Scholar 

  5. Oruç E.E., Rollas S., Kabasakal L., Uysal MK. (1999): The in vivo metabolism of 5-(4-nitrophenyl)-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats. Drug Metab. and Drug Interact., 15,127–140.

    Google Scholar 

  6. Gülerman N.N., Oruç E.E., Kartal F., Rollas S. (2000): The in vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl)methylene] hydrazide in rats. Eur. J. Drag Metab. Pharmacokinet., 25(2), 103–108.

    Article  Google Scholar 

  7. Kaymakcioglu B.K., Rollas S., Kartal-Aricioglu F. (2003): In vivo metabolism of itN-phenyl-N’-(33-dimethylpyrazole-4-yl)thioureain rats. Eur. J. Drug Metab Pharmacokinet., 28(4), 273–278.

    CAS  PubMed  Google Scholar 

  8. Yilmaz F., Ülgen M., Doĝruer D.S., Çakir B., Şahin M.F. (1999): The in vivo hepatic metabolism of l-phenyl-2-(2-benzothiazoltaone-3-yl)ethanone and their reduced derivatives. Exp. Toxic. Pathol., 51,442–445.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oruç, E.E., Ünsal, O., Balkan, A. et al. The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats. European Journal of Drug Metabolism and Pharmacokinetics 31, 21–25 (2006). https://doi.org/10.1007/BF03190638

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190638

Keywords

Navigation